Terminated PHASE2 INTERVENTIONAL 6-arm NCT00698789

Evaluate the Safety and Tolerability of INCB019602 When Administered With Metformin in Patients With Type 2 Diabetes

A Double-blind, Placebo Controlled, Randomized Study to Evaluate the Safety and Tolerability of INCB019602 Plus Metformin Compared to Metformin Alone in Type 2 Diabetic Subjects

Sponsor: Incyte Corporation

Conditions Type 2 Diabetes

Interventions INCB019602 Metformin Placebo

Updated 8 times since 2017 Last updated: Oct 25, 2012 Started: May 31, 2008 Primary completion: Feb 28, 2009 Completion: Jun 30, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Study ended after diabetes development plan review. .

Other terminated trials from Incyte Corporation

More terminations from Incyte Corporation

Other Type 2 Diabetes trials with similar outcome

Browse all Type 2 Diabetes trials

Listed as NCT00698789, this PHASE2 trial focuses on Type 2 Diabetes and remains terminated or withdrawn. Sponsored by Incyte Corporation, it has been updated 8 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Terminated PHASE2
Sep 2024 — Sep 2025 [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Apr 2022 — Jul 2024 [monthly]

Terminated PHASE2
Jan 2021 — Apr 2022 [monthly]

Terminated PHASE2

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Terminated PHASE2
Feb 2017 — Jun 2018 [monthly]

Terminated PHASE2
Jan 2017 — Feb 2017 [monthly]

Terminated PHASE2

First recorded

May 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Incyte Corporation

Data source: Incyte Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Charlotte, United States , Chula Vista, United States , Colorado Springs, United States , Dearborn, United States , East Providence, United States , Elizabeth, United States , Los Angeles, United States , Mission Viejo, United States , Oklahoma City, United States , Omaha, United States and 12 more locations